Redhill Biopharma Ltd. Press Releases

RDHL 
$12.15
*  
0.49
3.88%
Get RDHL Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading RDHL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
RedHill Biopharma Acquires Technology from University of Minnesota as Part of Ongoing RHB-104 Phase III Crohn's Program
12/18/2014 6:05:00 AM - GlobeNewswire


RedHill Biopharma Announces First Patients Enrolled in the Phase III Study of RHB-102 (BEKINDA(TM)) for Gastroenteritis and Gastritis
12/17/2014 6:05:00 AM - GlobeNewswire


RedHill Biopharma Submits BEKINDA(TM) (RHB-102) European Marketing Authorization Application for Oncology Support
12/9/2014 6:00:00 AM - GlobeNewswire


RedHill Biopharma to Sponsor and Exhibit Its Ongoing Phase III Crohn''s Program at the Israeli IBD Society Meeting
12/2/2014 7:00:00 AM - GlobeNewswire


IntelGenx and RedHill Biopharma Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines
12/1/2014 8:03:00 AM - GlobeNewswire


RedHill Biopharma and IntelGenx Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines
12/1/2014 8:00:00 AM - GlobeNewswire


FDA Grants QIDP Fast-Track Designation to RedHill Biopharma''s Phase III H. pylori Drug RHB-105
11/10/2014 7:28:00 AM - GlobeNewswire


RedHill Biopharma Reports Results for the Third Quarter of 2014
11/10/2014 6:30:00 AM - GlobeNewswire


RedHill Biopharma to Host Third Quarter 2014 Financial Results Conference Call on November 10, 2014
10/28/2014 7:00:00 AM - GlobeNewswire


RedHill Biopharma to Present at the 20th Annual BIO-Europe International Partnering Conference
10/22/2014 8:00:00 AM - GlobeNewswire


IntelGenx and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R)
10/1/2014 8:02:00 AM - GlobeNewswire


RedHill Biopharma and IntelGenx Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R) (formerly RHB-103)
10/1/2014 8:00:00 AM - GlobeNewswire